This Government Contract opportunity from Department Of Defense was posted on September 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Sodium Chloride Injection Supplier

Closed

Federal

Submission Closed09/08/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Zinc Oxide Ointment Supplier

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Levofloxacin Tablets (250 MG)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Hydrogen Peroxide Topical Solution

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0041

Solicitation SPE2DP-27-T-0041, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of Zinc Oxide Ointment USP. The required product is a topical skin protectant containing 20% zinc oxide, delivered in 1oz (28.4gm) collapsible tubes. The solicitation consists of two line items: CLIN 0001 for 10 units and CLIN 0002 for 5 units. The items must be stored at controlled room temperature not exceeding 30 degrees Celsius (86 degrees Fahrenheit) and have a non-extendable shelf life of 36 months. Delivery is required within 5 days after order, with an original required delivery date of October 2, 2026. Shipping is FOB Destination, with inspection and acceptance also occurring at the destination. The contractor must use the fastest traceable means for shipping and is prohibited from using Parcel Post. Packaging must comply with RP001 DLA Packaging Requirements and MIL-STD-129, with specific medical marking required per Medical Marking Standard No. 1. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it shall be commercially packaged per ASTM D3951. The contract incorporates various FAR and DFARS clauses, including requirements for combating trafficking in persons, safeguarding covered defense information, and adherence to the Buy American and Balance of Payments Program for quotes above the micro-purchase threshold. Payment and invoicing must be processed electronically through the Wide Area WorkFlow system. This is an FDA-regulated drug or device, and the contracting official must confirm the product specialist's referral in EBS.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0060

Solicitation SPE2DP-27-T-0060 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Levofloxacin Tablets, 250 MG, in quantities of 50 per bottle. The requirement consists of two line items: CLIN 0001 for 10 bottles and CLIN 0002 for 1 bottle, identified by NSN 6505014446634. These FDA-regulated drugs must be stored at medical controlled room temperature and maintain a non-extendable shelf life of 24 months (Type I, Code M). Delivery is required within 5 days after order, with FOB destination terms for locations in Fort Drum, New York, and Vilseck, Germany. The contract mandates strict adherence to Medical Marking Standard No. 1 and DLA packaging requirements RP001, with general preservation following MIL-STD-2073-1E. Non-hazardous materials must be commercially packaged per ASTM D3951, while hazardous materials require packaging per TQ requirement IP025 and FED-STD-313. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including those regarding safeguarding covered defense information, combating trafficking in persons, and the Buy American Act. Inspection and acceptance are conducted at the destination per FAR 52.246-2.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Omeprazole Extended-Release ManufacturerThis subcontract opportunity is for the manufacture and supply of finished Omeprazole Extended-Release medication to support prime contractors under the Department of Defense Medical Supply Chain Pharm FSA. The selected provider must produce the pharmaceutical product in accordance with NSN 016247068, FDA standards, and the DLA Master List of Technical and Quality Requirements. Performance of this contract takes place in Watervliet, New York. To be eligible, manufacturers must possess an FDA Manufacturing License and maintain strict cGMP compliance. The technical requirements specifically mandate the use of clean-room facilities and specialized extended-release formulation technology to ensure the delivery of a compliant finished pharmaceutical product. Responses for this requirement are due by October 13, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Hydrogen Peroxide Topical Solution

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Triiodothyronine (T3) Reagent Sets

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Citalopram Hydrobromide Tablets (20 MG)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Alcohol-Based Hand Sanitizer (4 fl oz)

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Blood Chemistry Controls Supplier

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Valacyclovir Hydrochloride Tablets Supplier

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 8 days

AI Contract Overview

This subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the supply of pharmaceutical-grade 0.9 percent Sodium Chloride Injection for prime contractors. The required product consists of 100 ML volumes in 150 ML fill plastic containers, packaged in 64-count units. All supplies must adhere to FDA medical pharmaceutical standards for injectables and comply with NSN 6505. The contract is categorized under NAICS code 325412 and specifies a place of performance at Fort Drum, New York. Successful providers must ensure that shipments are delivered within 10 days following the order date. The solicitation was posted on September 2, 2026, with a response deadline of September 8, 2026.

General Info

DoD subcontract for pharmaceutical 0.9% Sodium Chloride injections delivered to Fort Drum, NY.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

FORT DRUM, NY, 13602-5000, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-4876.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

SODIUM CHLORIDE INJECT

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedSep 2

subcontract

Response DeadlineSep 8

Deadline has passed

Submission Closed

09/08/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressN/A

ContactsNo contact information available

Full Description

Supplies 0.9% Sodium Chloride Injection for prime contractors delivering DLA supply contracts. Provides pharmaceutical-grade saline in 100 ML volume within 150 ML fill plastic containers, delivered in 64-count packages. Must meet FDA medical pharmaceutical standards for injectables and comply with NSN 6505. Delivers shipments within 10 days after date of order.